Vaccinex (VCNX) Stock Statistics & Valuation Metrics

Vaccinex has a market cap or net worth of $2.33M. The enterprise value is $1.65M.

Vaccinex has 2,676,637 shares outstanding. The number of shares has decreased by -2.65% in one year.

Vaccinex’s return on equity (ROE) is 0.69 and return on invested capital (ROIC) is 252.27%.

The current PE Ratio of Vaccinex is ―. Vaccinex’s PEG ratio is 0.00705.

In the last 12 months, Vaccinex had revenue of 2.10M and earned -5.26M in profits. Earnings per share was -1.97.

In the last 12 months, operating cash flow was -16.19M and capital expenditures -22.00K, giving a free cash flow of -16.21M billion.

Vaccinex pays an annual dividend of ―, resulting in a dividend yield of ―

Vaccinex upcoming earnings date is Nov 16, 2026, TBA (Confirmed).

Vaccinex as a current ratio of 0.45, with Debt / Equity ratio of -72.68%

In the past 12 months, Vaccinex has paid 0.00 in taxes.

Vaccinex EV to EBITDA ratio is -1.59, with an EV/FCF ratio of -1.28.

Vaccinex has $1.11M in cash and marketable securities with $25.00K in debt, giving a net cash position of $1.08M billion.

Gross margin is 98.33%, with operating margin of -249.74%, and net profit margin of -251.07%.

The average price target for Vaccinex is ―, which is 11.43% higher than the current price. The consensus rating is ―